Works matching IS 24501654 AND DT 2024 AND VI 20 AND IP 3

Results: 8

Diagnosis and treatment of patients with breast cancer and mutation in the BRCA1/2 genes.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 222, doi. 10.5603/OCP.2023.0035

By:

Kufel-Grabowska, Joanna;
Wasąg, Bartosz

Publication type:

Article

Sotorasib for non-small cell lung cancer -- current options and perspectives.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 215, doi. 10.5603/ocp.97414

By:

Knetki-Wróblewska, Magdalena;
Wasąg, Bartosz

Publication type:

Article

Pembrolizumab in combination with chemotherapy in patients with advanced squamous cell lung cancer -- clinical trials and real-world data.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 209, doi. 10.5603/OCP.2023.0047

By:

Knetki-Wróblewska, Magdalena;
Kowalski, Dariusz M.

Publication type:

Article

Clinical and economic benefits of using next-generation sequencing in the diagnostics of patients with non-small cell lung cancer with rare mutations.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 201, doi. 10.5603/OCP.2023.0044

By:

Stencel, Katarzyna;
Wasąg, Bartosz;
Pruszko, Cezary;
Dąbrowska, Krystyna;
Książek, Paweł;
Dziadek, Karolina;
Bryl, Maciej;
Krzakowski, Maciej

Publication type:

Article

Systemic treatment of patients with advanced pancreatic cancer -- is there still a place for gemcitabine in the first-line setting? Experience of Polish oncology centers.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 190, doi. 10.5603/ocp.97305

By:

Raczyński, Ireneusz;
Zając, Patryk;
Streb, Joanna;
Czartoryska-Arłukowicz, Bogumiła;
Chruściana-Bołtuć, Aleksandra;
Talerczyk, Małgorzata;
Wierzbicka, Katarzyna;
Siedlaczek, Agnieszka;
Radecka, Weronika;
Jurczyk, Michał;
Radecka, Barbara

Publication type:

Article

Non-drug related costs of treatment with pertuzumab and trastuzumab in HER2-positive breast cancer patients in Poland.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 181, doi. 10.5603/ocp.97426

By:

Seweryn, Michał;
Banaś, Tomasz;
Augustyńska, Joanna;
Leszczyńska, Agnieszka;
Potocki, Paweł M.

Publication type:

Article

Predictive factors of hepatotoxicity in immunotherapy with checkpoint inhibitors in patients treated for melanoma and kidney cancer.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 175, doi. 10.5603/OCP.2023.0048

By:

Malik, Mateusz;
Chowaniec, Zbyszko;
Kempa-Kamińska, Natasza;
Błaszczyk, Jerzy;
Filipczyk-Cisarż, Emilia

Publication type:

Article

Management of melanoma central nervous system metastases.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 161, doi. 10.5603/OCP.2023.0042

By:

Rutkowski, Piotr;
Kiprian, Dorota;
Świtaj, Tomasz;
Michalik, Radosław;
Spałek, Mateusz;
Kozak, Katarzyna;
Mandat, Tomasz;
Cybulska-Stopa, Bożena;
Dudzisz-Śledź, Monika

Publication type:

Article